1. Home
  2. CYTK vs M Comparison

CYTK vs M Comparison

Compare CYTK & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • M
  • Stock Information
  • Founded
  • CYTK 1997
  • M 1830
  • Country
  • CYTK United States
  • M United States
  • Employees
  • CYTK N/A
  • M N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • M Department/Specialty Retail Stores
  • Sector
  • CYTK Health Care
  • M Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • M Nasdaq
  • Market Cap
  • CYTK 4.6B
  • M 4.9B
  • IPO Year
  • CYTK 2004
  • M N/A
  • Fundamental
  • Price
  • CYTK $59.89
  • M $17.82
  • Analyst Decision
  • CYTK Buy
  • M Hold
  • Analyst Count
  • CYTK 16
  • M 10
  • Target Price
  • CYTK $76.73
  • M $15.72
  • AVG Volume (30 Days)
  • CYTK 2.5M
  • M 8.9M
  • Earning Date
  • CYTK 11-05-2025
  • M 11-25-2025
  • Dividend Yield
  • CYTK N/A
  • M 4.09%
  • EPS Growth
  • CYTK N/A
  • M 304.55
  • EPS
  • CYTK N/A
  • M 1.77
  • Revenue
  • CYTK $85,738,000.00
  • M $22,701,000,000.00
  • Revenue This Year
  • CYTK $363.61
  • M N/A
  • Revenue Next Year
  • CYTK $64.08
  • M N/A
  • P/E Ratio
  • CYTK N/A
  • M $10.10
  • Revenue Growth
  • CYTK 2635.74
  • M N/A
  • 52 Week Low
  • CYTK $29.31
  • M $9.76
  • 52 Week High
  • CYTK $61.19
  • M $18.47
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 75.04
  • M 61.61
  • Support Level
  • CYTK $47.22
  • M $17.54
  • Resistance Level
  • CYTK $50.78
  • M $18.47
  • Average True Range (ATR)
  • CYTK 2.30
  • M 0.56
  • MACD
  • CYTK 0.66
  • M -0.11
  • Stochastic Oscillator
  • CYTK 90.55
  • M 60.19

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.

Share on Social Networks: